Immunophenotypical Results in MM and Primary PCL
| Immunophenotype . | MM . | PCL . | P . |
|---|---|---|---|
| BB4+ | 99% | 100% | .90482 |
| CD10+ | 6% | 6% | .72808 |
| CD13+ | 31% | 23% | .40456 |
| CD15+ | 7% | 8% | .60321 |
| CD20+ | 17% | 50% | .00139 |
| CD38+ | 100% | 100% | — |
| CD56+ | 70% | 45% | .02217 |
| CD9+ | 78% | 46% | .01984 |
| CD117+ | 43% | 0% | .03646 |
| DR+ | 56% | 21% | .01549 |
| Immunophenotype . | MM . | PCL . | P . |
|---|---|---|---|
| BB4+ | 99% | 100% | .90482 |
| CD10+ | 6% | 6% | .72808 |
| CD13+ | 31% | 23% | .40456 |
| CD15+ | 7% | 8% | .60321 |
| CD20+ | 17% | 50% | .00139 |
| CD38+ | 100% | 100% | — |
| CD56+ | 70% | 45% | .02217 |
| CD9+ | 78% | 46% | .01984 |
| CD117+ | 43% | 0% | .03646 |
| DR+ | 56% | 21% | .01549 |